Artículos por temáticas

Sleep in frontotemporal dementia is equally or possibly more disrupted, and at an earlier stage, when compared to sleep in Alzheimer's disease

Bonakis A, Economou NT, Paparrigopoulos T, Bonanni E, Maestri M, Carnicelli L, Di Coscio E, Ktonas P, Vagiakis E, Theodoropoulos P, Papageorgiou SG.

J Alzheimers Dis. 2014;38(1):85-91. doi: 10.3233/JAD-122014.

Function and dysfunction of presenilin

Shen J.

Neurodegener Dis. 2014;13(2-3):61-3. doi: 10.1159/000354971. Epub 2013 Oct 2.

Behavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines

Puzzo D, Lee L, Palmeri A, Calabrese G, Arancio O.

Biochem Pharmacol. 2014 Apr 15;88(4):450-67. doi: 10.1016/j.bcp.2014.01.011. Epub 2014 Jan 21.

Dysregulation of neurotrophic and haematopoietic growth factors in Alzheimer's disease: from pathophysiology to novel treatment strategies

Sopova K, Gatsiou K, Stellos K, Laske C.

Curr Alzheimer Res. 2014 Jan;11(1):27-39. doi: 10.2174/1567205010666131120100743.

MicroRNA-323-3p with clinical potential in rheumatoid arthritis, Alzheimer's disease and ectopic pregnancy

Xu T, Li L, Huang C, Li X, Peng Y, Li J.

Expert Opin Ther Targets. 2014 Feb;18(2):153-8. doi: 10.1517/14728222.2014.855201. Epub 2013 Nov 27.

The emerging role of glutathione in Alzheimer's disease

Saharan S, Mandal PK.

J Alzheimers Dis. 2014;40(3):519-29. doi: 10.3233/JAD-132483.

Wnt/β-catenin signaling in Alzheimer's disease

De Ferrari GV, Avila ME, Medina MA, Perez-Palma E, Bustos BI, Alarcon MA.

CNS Neurol Disord Drug Targets. 2014;13(5):745-54. doi: 10.2174/1871527312666131223113900.

Role of synaptic activity in the regulation of amyloid beta levels in Alzheimer's disease

Cheng X, Wu J, Geng M, Xiong J.

Neurobiol Aging. 2014 Jun;35(6):1217-32. doi: 10.1016/j.neurobiolaging.2013.11.021. Epub 2013 Nov 28.

[Cellular models for individualized medicine in Alzheimer's disease using patient-derived induced pluripotent stem cells]

Asai M, Shirotani K, Kondo T, Inoue H, Iwata N.

Nihon Yakurigaku Zasshi. 2014 Jan;143(1):23-6. doi: 10.1254/fpj.143.23.

Pathogenesis of Alzheimer disease: role of oxidative stress, amyloid-β peptides, systemic ammonia and erythrocyte energy metabolism

Kosenko EA, Solomadin IN, Tikhonova LA, Reddy VP, Aliev G, Kaminsky YG.

CNS Neurol Disord Drug Targets. 2014 Feb;13(1):112-9. doi: 10.2174/18715273113126660130.

Positive and negative effects of prostaglandins in Alzheimer's disease

Fattahi MJ, Mirshafiey A.

Psychiatry Clin Neurosci. 2014 Jan;68(1):50-60. doi: 10.1111/pcn.12092. Epub 2013 Sep 2.

A novel p.Leu(381)Phe mutation in presenilin 1 is associated with very early onset and unusually fast progressing dementia as well as lysosomal inclusions typically seen in Kufs disease

Dolzhanskaya N, Gonzalez MA, Sperziani F, Stefl S, Messing J, Wen GY, Alexov E, Zuchner S, Velinov M.

J Alzheimers Dis. 2014;39(1):23-7. doi: 10.3233/JAD-131340.

What should we do if we were wrong and Alzheimer was right?

Breitner JC.

Int Psychogeriatr. 2014 Jan;26(1):3-6. doi: 10.1017/S1041610213001749. Epub 2013 Oct 18.

Differences between amyloid-β aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer's disease

Kotler SA, Walsh P, Brender JR, Ramamoorthy A.

Chem Soc Rev. 2014 Oct 7;43(19):6692-700. doi: 10.1039/c3cs60431d.

Neuropsychological correlates of behavioral symptoms in Alzheimer's disease, frontal variant of frontotemporal, subcortical vascular, and lewy body dementias: a comparative study

Perri R, Monaco M, Fadda L, Caltagirone C, Carlesimo GA.

J Alzheimers Dis. 2014;39(3):669-77. doi: 10.3233/JAD-131337.